NONE
1.Labor, HHS & Education Appropriations-Congressionally directed spending (CDS) Request
2.Funding Request-Establishment of Bioinformatics & Systems Vaccination Unit within Center for Vaccine Development & Global Health
3.Funding Request-Kahlert Institute for Addiction Medicine-FAIR Clinic
4.Funding Request-Rise Early Learning & Family Support Center
5.Funding Request-UM-MIND-X-CHANGE
Duration: December 19, 2013
to
present
General Issues: Health Issues , Education , Defense , Budget/Appropriations , Immigration , Medical/Disease Research/Clinical Labs , Science/Technology , Medicare/Medicaid , Law Enforcement/Crime/Criminal Justice , Taxation/Internal Revenue Code , Pharmacy , Welfare
Spending: about $405,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Defense - Dept of (DOD)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Kevin Patrick Kelly Projects Director to Sen. Barbara Mikulski (1993-1997)
Sen. Mikulski, special projects director, 1993-1997
Sen. Mikulski, special projects director 1993-1997
Sen. Barbara Mikulski, special projects director 1993-1997
Sen. Barbara Mikulski, special projects director, 1993-1997
Sen. Mikulski, special projects dir. 1993-1997
Special Projects Dir. for Sen. Barbara Mikulski, 1993-1997
Senator Barbara A. Mikulski, Special Projects Director, 1993-1997
Kevin Kelly Sen. Mikulski, special projects dir. 1003-1997
Senator Barbara A. Mikulski, Special Projects Director, 1993-1997
Rachel Tabakman n/a
Jeffrey Grossi n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 11.
Original Filing: 301548110.xml
Type of Issue
Health Issues/Disease Research/Clinical Labs/Technology/Medicaid/Crime/Criminal Justice
Lobbying Issues
1.Labor, HHS & Education Appropriations-Congressionally directed spending (CDS) Request
2.Funding Request-Establishment of Bioinformatics & Systems Vaccination Unit within Center for Vaccine Development & Global Health
3.Funding Request-Kahlert Institute for Addiction Medicine-FAIR Clinic
4.Funding Request-Rise Early Learning & Family Support Center
5.Funding Request-UM-MIND-X-CHANGE
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 16.
Original Filing: 301525307.xml
Type of Issue
Health Issues/Disease Research/Clinical Labs/Technology/Medicaid/Crime/Criminal Justice
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program, Reconstructive Transplantation, and Combat Medical Skills Sustainment Training
2. Labor, Education, and Related Agencies, Appropriations, HRSA directed spending request/FIPSE directed spending request/SAMSHA directed spending request, ARPA-H-budget and agency location
3. CJS-Dept. of Commerce-NIST-Cryo-EM - directed spending request Appropriations
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 19, 2023.
Original Filing: 301506384.xml
Type of Issue
Health Issues/Disease Research/Clinical Labs/Technology/Medicaid/Crime/Criminal Justice
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant, Orthopedic Research and Combat Medical Skills Sustainment Training directed spending request
Agencies Lobbied
U.S. Senate
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program, Reconstructive Transplantation, and Combat Medical Skills Sustainment Training
2. Labor, Health and Human Services, Education, and Related Agencies, Appropriations, HRSA directed spending request/FIPSE directed spending request/SAMSHA directed spending request, ARPA-H-budget and agency location
3. CJS-Dept. of Commerce-NIST-Cryo-EM - directed spending request Appropriations
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 18, 2023.
Original Filing: 301479328.xml
Type of Issue
Health Issues/Medicaid/Crime/Criminal Justice
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant, Orthopedic Research and Combat Medical Skills Sustainment Training directed spending request
Agencies Lobbied
U.S. Senate
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program, Reconstructive Transplantation, and Combat Medical Skills Sustainment Training
2. Labor, Health and Human Services, Education, and Related Agencies, Appropriations, HRSA directed spending request/FIPSE directed spending request/SAMSHA directed spending request, ARPA-H-budget and agency location
3. CJS-Dept. of Commerce-NIST-Cryo-EM - directed spending request Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
ARPA-H, budget and agency location
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
ARPA-H - budget and location
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 4, 2023.
Original Filing: 301448959.xml
Type of Issue
Health Issues/Medicaid/Crime/Criminal Justice
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant, Orthopedic Research and Combat Medical Skills Sustainment Training directed spending request
Agencies Lobbied
U.S. Senate
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program, Reconstructive Transplantation, and Combat Medical Skills Sustainment Training
2. Labor, Health and Human Services, Education, and Related Agencies, Appropriations, HRSA directed spending request/FIPSE directed spending request/SAMSHA directed spending request, ARPA-H-budget and agency location
3. CJS-Dept. of Commerce-NIST-Cryo-EM - directed spending request Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
ARPA-H, budget and agency location
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
ARPA-H - budget and location
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 18, 2023.
Original Filing: 301431232.xml
Type of Issue
Health Issues/Medicaid/Crime/Criminal Justice
Lobbying Issues
Appropriations for Dept of Education - Cryo EM - FIPSE directed spending request
CURE Scholars - FIE directed spending request
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant and Orthopedic Research
Agencies Lobbied
U.S. Senate
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program and Reconstructive Transplantation
2. Labor, Health and Human Services, Education, and Related Agencies, Appropriations, FIPSE directed spending request/FIE directed spending request-CURE Scholars, ARPA-H-budget and agency location
3. CJS - Dept. of Justice, Train the Trainer-direct spending request, Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
ARPA-H, budget and agency location
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
ARPA-H - budget and agency location
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 18, 2022.
Original Filing: 301406751.xml
Type of Issue
Health Issues/Medicaid/Crime/Criminal Justice
Lobbying Issues
Appropriations for Dept of Education - Cryo EM - FIPSE directed spending request
CURE Scholars - FIE directed spending request
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant and Orthopedic Research
Agencies Lobbied
U.S. Senate
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program and Reconstructive Transplantation
2. Labor, Health and Human Services, Education, and Related Agencies, Appropriations, FIPSE directed spending request/FIE directed spending request-CURE Scholars, ARPA-H-budget and agency location
3. CJS - Dept. of Justice, Train the Trainer-direct spending request, Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
ARPA-H, budget and agency location
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
ARPA-H - budget and agency location
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 18, 2022.
Original Filing: 301382735.xml
Type of Issue
Health Issues/Disease Research/Clinical Labs/Technology/Medicaid/Crime/Criminal Justice
Lobbying Issues
Appropriations for Dept of Education - Cryo EM - FIPSE directed spending request
CURE Scholars - FIE directed spending request
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant and Orthopedic Research
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program and Reconstructive Transplantation
2. Labor, Health and Human Services, Education, and Related Agencies Appropriations - Dept of Education - Promise Neighborhoods, FIPSE directed spending request/FIE directed spending request-CURE Scholars
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 19, 2022.
Original Filing: 301360548.xml
Type of Issue
Health Issues/Disease Research/Clinical Labs/Technology/Medicaid/Crime/Criminal Justice
Lobbying Issues
Appropriations for Dept of Education - Cryo EM - FIPSE directed spending request
CURE Scholars - FIE directed spending request
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant and Orthopedic Research
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program and Reconstructive Transplantation
2. Labor, Health and Human Services, Education, and Related Agencies Appropriations - Dept of Education - Promise Neighborhoods, FIPSE directed spending request/FIE directed spending request-CURE Scholars
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 18, 2022.
Original Filing: 301325821.xml
Lobbying Issues
H.R. 708 TREAT Act - Telehealth
Lobbying Issues
Appropriations for Dept of Education - Promise Neighborhoods
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant and Orthopedic Research
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program and Reconstructive Transplantation
2. Commerce, Justice, Science Appropriations - Dept of Justice - Cannabis Research, Dept of Justice - National Institute of Justice
3. Homeland Security Appropriations - Cybersecurity
4. Labor, Healthy and Human Services, Education, and Related Agencies Appropriations - Dept of Education - Promise Neighborhoods, HHS - HRSA directed spending request
5. H.R. 3684 - Infrastructure Investment & Jobs Act
6. H.R. 5376 Build Back Better Act
Agencies Lobbied
U.S. Senate
Type of Issue
Immigration/Medicaid
Lobbying Issues
H.R. 3684 - Infrastructure Investment & Jobs Act
H.R. 5376 Build Back Better Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 3684 Infrastructure Investment & Jobs Act
H.R. 5376 Build Back Better Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Institute of Justice funding for Higher Ed and Police Partnerships
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2021
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 13, 2021.
Original Filing: 301298412.xml
Lobbying Issues
H.R. 708 TREAT Act - Telehealth
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for Dept of Education - Promise Neighborhoods
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant and Orthopedic Research
Agencies Lobbied
U.S. Senate
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program and Reconstructive Transplantation
2. Commerce, Justice, Science Appropriations - Dept of Justice - Cannabis Research, Dept of Justice - National Institute of Justice
3. Homeland Security Appropriations - Cybersecurity
4. Labor, Healthy and Human Services, Education, and Related Agencies Appropriations - Dept of Education - Promise Neighborhoods, HHS - HRSA directed spending request
5. H.R. 3684 - Infrastructure Investment & Jobs Act
Agencies Lobbied
U.S. Senate
Type of Issue
Immigration/Medicaid
Lobbying Issues
H.R. 3684 - Infrastructure Investment & Jobs Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 3684 Infrastructure Investment & Jobs Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Institute of Justice funding for Higher Ed and Police Partnerships
Agencies Lobbied
U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2021
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 16, 2021.
Original Filing: 301277541.xml
Lobbying Issues
Appropriations for Dept of Education - Promise Neighborhoods
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Appropriations Budget Legislation - Reconstructive Transplant and Orthopedic Research
Agencies Lobbied
U.S. Senate
Lobbying Issues
1. Defense Appropriations - Defense Health Service - Orthopedic Research Program and Reconstructive Transplantation
2. Commerce, Justice, Science Appropriations - Dept of Justice - Cannabis Research, Dept of Justice - National Institute of Justice
3. Homeland Security Appropriations - Cybersecurity
4. Labor, Healthy and Human Services, Education, and Related Agencies Appropriations - Dept of Education - Promise Neighborhoods, HHS - HRSA directed spending request
Agencies Lobbied
U.S. Senate
Type of Issue
Immigration/Disease Research/Clinical Labs/Technology/Medicaid/Crime/Criminal Justice
1st Quarter, 2021
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 14, 2021.
Original Filing: 301252913.xml
Lobbying Issues
Defense Appropriations Budget Legislation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Type of Issue
Immigration/Disease Research/Clinical Labs/Technology/Medicaid/Crime/Criminal Justice
4th Quarter, 2020
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 19, 2021.
Original Filing: 301234628.xml
Lobbying Issues
H.R. 7614 Labor, HHS and Education Appropriations (NIH)
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
H.R. 133 - United States-Mexico Economic Partnership Act [Consolidated Appropriations Act, 2021]
HR 8505 - "To amend title XVII of the Social Security Act....." (Medicare physician fee schedule)
HR 8702 - "Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020" (Medicare physician fee schedule)
Agencies Lobbied
U.S. Senate
Lobbying Issues
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
H.R. 133 - United States-Mexico Economic Partnership Act [Consolidated Appropriations Act, 2021]
S 4865 - Full-Service Community School Expansion Act of 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 133 - United States-Mexico Economic Partnership Act [Consolidated Appropriations Act, 2021]
Agencies Lobbied
U.S. Senate
Lobbying Issues
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
H.R. 133 - United States-Mexico Economic Partnership Act [Consolidated Appropriations Act, 2021]
Agencies Lobbied
U.S. Senate
Lobbying Issues
CARES Act funding H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
H.R. 133 - United States-Mexico Economic Partnership Act [Consolidated Appropriations Act, 2021]
HR 8505 - "To amend title XVII of the Social Security Act....." (Medicare physician fee schedule)
HR 8702 - "Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020" (Medicare physician fee schedule)
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 133 - United States-Mexico Economic Partnership Act [Consolidated Appropriations Act, 2021]
S 2032 - Cannabidiol and Marijuana Research Expansion Act
Lobbying Issues
HR 8505 - "To amend title XVII of the Social Security Act....." (Medicare physician fee schedule)
HR 8702 - "Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020" (Medicare physician fee schedule)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.4791 Community-Based Response Act
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2020
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 16, 2020.
Original Filing: 301211626.xml
Lobbying Issues
H.R. 7614 Labor, HHS and Education Appropriations (NIH)
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
H.R. 7608 State, Foreign Operations (PEPFAR)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7614 Labor, HHS - Education Appropriations (Promise Heights Neighborhood Program)
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
Department of Education Grants Opportunities
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7617 - Defense Appropriations (Defense Health Program - Reconstructive Transplant and Orthopedic Trauma)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7667 Commerce, Justice, and Science Appropriations (DOJ)
H.R. 7617 Defense Appropriations (Defense Health Program)
H.R. 7614 Labor, HHS and Education Appropriations (NIH and Dept of Education)
H.R. 7608 State, Foreign Operations Appropriations (Global Health Program)
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
Agencies Lobbied
U.S. Senate
Lobbying Issues
Presidential Proclamation 10014 (H-1B, H-28, J Visa)
Executive Order on Student and Exchange Visitor Program (SEVP)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7614 Labor HHS - Education Appropriations (NIH)
CARES Act funding H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 7667 Commerce, Justice, Science Appropriations (DOJ - Scientific Research on Cannabis)
2nd Quarter, 2020
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 17, 2020.
Original Filing: 301191930.xml
Lobbying Issues
H.R. 7614 Labor, HHS and Education Appropriations (NIH)
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
H.R. 7608 State, Foreign Operations (PEPFAR)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7614 Labor, HHS - Education Appropriations (Promise Heights Neighborhood Program)
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
Department of Education Grants Opportunities
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7617 - Defense Appropriations (Defense Health Program - Reconstructive Transplant and Orthopedic Trauma)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7667 Commerce, Justice, and Science Appropriations (DOJ)
H.R. 7617 Defense Appropriations (Defense Health Program)
H.R. 7614 Labor, HHS and Education Appropriations (NIH and Dept of Education)
H.R. 7608 State, Foreign Operations Appropriations (Global Health Program)
CARES Act H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
Agencies Lobbied
U.S. Senate
Lobbying Issues
Presidential Proclamation 10014 (H-1B, H-28, J Visa)
Executive Order on Student and Exchange Visitor Program (SEVP)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7614 Labor HHS - Education Appropriations (NIH)
CARES Act funding H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act"
Vaccine and Treatment Evaluation Unit Grant (HHS, NIH, NIAID)
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 7667 Commerce, Justice, Science Appropriations (DOJ - Scientific Research on Cannabis)
1st Quarter, 2020
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on May 13, 2020.
Original Filing: 301182933.xml
Lobbying Issues
Appropriations for NIH
CURES Act
PEPFAR
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for Promise Neighborhoods Program
CARES Act
Department of Education Grants
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations in Defense Health Program for Reconstructive Transplant
Appropriations in Defense Health Program for Orthopedic Trauma
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for NIH, HHS, HRSA, DOJ,HUD,DOD, Education and State Department -Global Health Program
CARES Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for NIH
CARES Act funding
Vaccine and Treatment Evaluation Unit Grant (HHS, NIH, NIAID)
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Scientific Research on Cannabis/Medical Marijuana
Appropriations for DOJ regarding scientific research on cannabis
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 27, 2020.
Original Filing: 301130542.xml
Lobbying Issues
Appropriations for NIH
PCORI Reuathorization -H.R. 3030, the Patient-Centered Outcomes Research Extension Act of 2019
PEPFAR
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for Promise Neighborhoods Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations in Defense Health Program for Medical Modeling and Simulation
Lobbying Issues
Appropriations for NIH, NCI, HHS, HRSA, DOJ, Education and Global Health Program
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Appropriations for NIH
PCORI Reauthorization - H.R. 3030, the "Patient-Centered Outcomes Research Extension Act of 2019"
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2019
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 31, 2019.
Original Filing: 301080577.xml
Lobbying Issues
Appropriations for NIH
PCORI Reuathorization -H.R. 3030, the Patient-Centered Outcomes Research Extension Act of 2019
PEPFAR
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for Promise Neighborhoods Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations in Defense Health Program for Medical Modeling and Simulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for NIH, NCI, HHS, HRSA, DOJ, Education and Global Health Program
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Appropriations for NIH
PCORI Reauthorization - H.R. 3030, the "Patient-Centered Outcomes Research Extension Act of 2019"
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2019
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Aug. 2, 2019.
Original Filing: 301060605.xml
Lobbying Issues
Appropriations for NIH
PCORI Reuathorization -H.R. 3030, the Patient-Centered Outcomes Research Extension Act of 2019
PEPFAR
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for Promise Neighborhoods Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations in Defense Health Program for Medical Modeling and Simulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for NIH, NCI, HHS, HRSA, DOJ, Education and Global Health Program
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Appropriations for NIH
PCORI Reauthorization - H.R. 3030, the "Patient-Centered Outcomes Research Extension Act of 2019"
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2019
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on May 1, 2019.
Original Filing: 301040065.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations for Promise Neighborhoods Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Appropriations in Defense Health Program for Medical Modeling and Simulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Appropriations for NIH, NCI, HHS, HRSA, DOJ, Education and Global Health Program
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2018
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Dec. 19, 2018.
Original Filing: 301001534.xml
Lobbying Issues
health care research funding, NIH funding - indirect costs, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding, opioid addiction legislation, interprofessional education and training
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding, STEM pipeline funding, Higher Education Reauthorization, PROSPER Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Health Funding, reconstructive transplant funding, METRC/PRORP funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY19 appropriations, federally supported research funding
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.6149 - To amend the Internal Revenue Code of 1986 to exclude from gross income certain Federally-subsidized loan repayments for dental school faculty
Tax reform
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2018
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 1, 2018.
Original Filing: 300982090.xml
Lobbying Issues
health care research funding, NIH funding - indirect costs, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding, opioid addiction legislation, interprofessional education and training
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding, STEM pipeline funding, Higher Education Reauthorization, PROSPER Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Health Funding, reconstructive transplant funding, METRC/PRORP funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY19 appropriations, federally supported research funding
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.6149 - To amend the Internal Revenue Code of 1986 to exclude from gross income certain Federally-subsidized loan repayments for dental school faculty
Tax reform
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 2, 2018.
Original Filing: 300961881.xml
Lobbying Issues
health care research funding, NIH funding - indirect costs, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding, opioid addiction legislation, interprofessional education and training
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding, STEM pipeline funding, Higher Education Reauthorization, PROSPER Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Health Funding, reconstructive transplant funding, METRC/PRORP funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY19 appropriations, federally supported research funding
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 5, 2018.
Original Filing: 300942570.xml
Lobbying Issues
Health care reform efforts, health care research funding, NIH funding - indirect costs, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding, opioid addiction legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding, STEM pipeline funding, Higher Education Reauthorization
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Health Funding, reconstructive transplant funding, METRC/PRORP funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY18,19 appropriations, federally supported research funding
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 10, 2018.
Original Filing: 300922138.xml
Lobbying Issues
Health care reform efforts, health care research funding, NIH funding - indirect costs, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding, opioid addiction legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding, STEM pipeline funding, Higher Education Reauthorization
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Health Funding, reconstructive transplant funding, METRC/PRORP funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY18,19 appropriations, federally supported research funding
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Sept. 27, 2017.
Original Filing: 300900871.xml
Lobbying Issues
Health care reform efforts, health care research funding, NIH funding - indirect costs, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding, STEM pipeline funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Health Funding, reconstructive transplant funding, METRC/PRORP funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY18 appropriations, FY18 budget, federally supported research funding
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 3, 2017.
Original Filing: 300881705.xml
Lobbying Issues
American Health Care Act, health care research funding, NIH funding, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding, STEM pipeline funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Health Funding, reconstructive transplant funding, METRC/PRORP funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY17 / FY18 appropriations, FY18 budget, federally supported research funding
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 3, 2017.
Original Filing: 300862259.xml
Lobbying Issues
American Health Care Act, health care research funding, NIH funding, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding, STEM pipeline funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Defense Health Funding, reconstructive transplant funding, METRC/PRORP funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FY17 / FY18 appropriations, FY18 budget
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 20, 2017.
Original Filing: 300852328.xml
Lobbying Issues
healthcare research funding; NIH funding; Ryan White HIV/AIDS program funding; Cancer Center funding; reconstructive transplantation research funding; funding for nursing education and research; funding for FDA innovation programs
Lobbying Issues
Promise Neighborhoods program funding; STEM pipeline programs for K-12 students
3rd Quarter, 2016
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 17, 2016.
Original Filing: 300828935.xml
Lobbying Issues
healthcare research funding; NIH funding; Ryan White HIV/AIDS program funding; Cancer Center funding; reconstructive transplantation research funding; funding for nursing education and research; funding for FDA innovation programs
Lobbying Issues
Promise Neighborhoods program funding; STEM pipeline programs for K-12 students
2nd Quarter, 2016
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 19, 2016.
Original Filing: 300814592.xml
Lobbying Issues
healthcare research funding; NIH funding; Ryan White HIV/AIDS program funding; Cancer Center funding; reconstructive transplantation research funding; funding for nursing education and research; funding for FDA innovation programs
Lobbying Issues
Promise Neighborhoods program funding; STEM pipeline programs for K-12 students
1st Quarter, 2016
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 22, 2016.
Original Filing: 300804173.xml
Lobbying Issues
healthcare research funding; NIH funding; Ryan White HIV/AIDS program funding; Cancer Center funding; reconstructive transplantation research funding; funding for nursing education and research; funding for FDA innovation programs
Lobbying Issues
Promise Neighborhoods program funding; STEM pipeline programs for K-12 students
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 7, 2016.
Original Filing: 300769599.xml
Lobbying Issues
healthcare research funding; NIH funding; Ryan White HIV/AIDS program funding; Cancer Center funding; reconstructive transplantation research funding; funding for nursing education and research; funding for FDA innovation programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding; STEM pipeline programs for K-12 students
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 20, 2015.
Original Filing: 300759611.xml
Lobbying Issues
healthcare research funding; NIH funding; Ryan White HIV/AIDS program funding; Cancer Center funding; reconstructive transplantation research funding; funding for nursing education and research; funding for FDA innovation programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding; STEM pipeline programs for K-12 students
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 16, 2015.
Original Filing: 300736078.xml
Lobbying Issues
healthcare research funding; CHIP authorization; NIH funding; Ryan White HIV/AIDS program funding; Cancer Center funding; reconstructive transplantation research funding; funding for nursing education and research; funding for FDA innovation programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding; STEM pipeline programs for K-12 students
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 20, 2015.
Original Filing: 300721750.xml
Lobbying Issues
healthcare research funding; CHIP authorization; NIH funding; Ryan White HIV/AIDS program funding; Cancer Center funding; reconstructive transplantation research funding; funding for nursing education and research; funding for FDA innovation programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Promise Neighborhoods program funding; STEM pipeline programs for K-12 students
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 20, 2015.
Original Filing: 300701680.xml
Lobbying Issues
The University of Maryland, Baltimore (UMB) lobbied for health issues that included: funding to combat the Ebola crisis, reconstructive transplant research funding, nursing education funding, and legislation for provider status for pharmacists. UMB also lobbied for the inclusion of a medication therapy management program for the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
The University of Maryland, Baltimore lobbied Congress to establish a program aimed at elementary, middle and high school students that will assist in developing their interests in the life and bioscience fields in order to pursue related careers later in their lives.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300682851.xml
Lobbying Issues
Issues related to transplantation funding, medication therapy management programs, and provider status for pharmacists.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to funding for the National Institutes of Health and biomedical research, brain science, and nursing edcuation
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on July 18, 2014.
Original Filing: 300660612.xml
Lobbying Issues
FY2015 Appropriations legislation related to healthcare, education, and research funding; NIH funding as well as specific grant programs.
FY2015 Defense Authorization Act - Advocating for language that sets up an MTM program within TRICARE
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY2015 Appropriations - Education spending, specifically the Promise Neighborhoods grant program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY2015 Appropriations, related to health research funding and support for NIH
S.2115 American Cures Act - advocated in support of legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY2015 Defense Authorization Act - in support of language establishing an Medication Management Therapy program
FY'2015 Defense Appropriations legislation - in support of funding for reconstructive transplant research
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
In Q1, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on April 21, 2014.
Original Filing: 300644260.xml
Lobbying Issues
Reconstructive transplant funding in Department of Defense FY2015 appropriations bill; health and higher education funding in FY2015 Labor-HHS appropriations bill; NIH funding
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, University of Maryland, Baltimore (UMB) had in-house lobbyists. The report was filed on Jan. 21, 2014.
Original Filing: 300623807.xml
Lobbying Issues
Reconstructive transplant funding in Department of Defense appropriations bill; health and education funding in Labor-HHS appropriations bill; NIH funding
Agencies Lobbied
U.S. Senate
4th Quarter, 2013
University of Maryland, Baltimore (UMB) filed a lobbying registration on Dec. 18, 2013 for in-house lobbying efforts, effective Dec. 19, 2013.
Original Filing: 300610581.xml
Issue(s) they said they’d lobby about: NIH research funding, Defense appropriations, Higher Education Reauthorization Act .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...